View Clinical Trial (Medical Research Study)


Smoking Cessation and the Natural History of HIV-Associated Emphysema

Signup
Browse Studies

City:   Columbus
State:   Ohio
Zip Code:   43210
Conditions:   Smoking - HIV Infections
Purpose:   People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.
Study Summary:   HIV-infected smokers are at increased risk for life-threatening diseases, such as pneumonia. To date, very little is known about the tobacco consumption characteristics of this at-risk population of smokers, but it has been well documented that they are at high risk for smoking-related co-morbidities. In addition, few effective cessation strategies have been described in HIV-infected populations. A specialized smoking cessation that combines recommendations from an existing scientifically-valid clinical guideline with Motivational Interviewing a new pharmacotherapeutic agent, may be an effective mechanism to apply to this vulnerable population of smokers. This initial, efficacy investigation has the potential to guide future treatment and research pertaining to tobacco cessation, respiratory illness and HIV.
Criteria:   Inclusion Criteria: 1. 18 years of age and older; 2. diagnosis of HIV; 3. self-reported smoking on a daily basis; 4. provide informed written consent Exclusion Criteria: 1. persons with active psychosis or impaired mental status as judged by the clinic staff and confirmed with a Mini-Mental Status Exam) 2. unable to understand spoken English 3. age less than 18 years. 4. pregnant women
NCT ID:   NCT00701896
Primary Contact:   Principal Investigator
Philip T. Diaz, MD
Ohio State University

Philip T. T. Diaz, MD
Phone: 614-293-4978
Email: philip.diaz@osumc.edu
Backup Contact:   Email: janice.drake@osumc.edu
Janice E. Drake, CRTT
Phone: 614-366-2287
Location Contact:   Columbus, Ohio 43210
United States

Janice E. Drake, CRTT
Phone: 614-366-2287
Email: janice.drake@osumc.edu

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   August 30, 2014
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click I Am Interested In This Study

Full Name:
 
Email Address:
Confirm Email:
Daytime Phone (eg. 555-555-5555):
City:
State:
Zip Code:
Best Time to Call:
Questions/Comments: